A company negotiating or in the process of working a sales deal hoping for a buy-out would likely have all of its financial reports and audits in order and timely filed. The fact of the failure of GNBT to have timely filed its financials indicates that they are at a lost to perform a financial workup of assets and debts. I dont think a sale is in the cards for this reason.
No company is going to touch a company in financial reporting delinquency since it would taint the books of the purchasing firm upon acquisition.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links